Mission of the ELIPS® Program
Fighting infarction and atherosclerosis
Some 10,000 people die each year in Switzerland from myocardial infarction. Furthermore, 1 in 7 relapse in the following year! Infarction is a common and serious complication of a chronic disease: atherosclerosis.
Therapeutic progress has certainly improved treatment and has shortened the length of stay in the hospital. However, relapses depend on treatment adherence.
In view of this observation, the HUG has decided to launch a therapeutic education program, called ELIPS®.